CompuGROUP Experiences Strong Increase of Revenues

CompuGROUP Holding AGBoth revenues and earnings of CompuGROUP have increased significantly in the business year 2007, and the company is now looking back on the most successful business year in its history. All projected revenues and targeted results have been met. Both the Health Provider Services (HPS) and Health Connectivity Services (HCS) segments have shown an excellent development compared to the previous year's results and are meeting the company's expectations. Due to further investments in the strategically important vita-X product - web-based electronic patient file - the Electronic Patient Services segment (EPS) could improve its results only marginally.

Strong Revenue Growth
In the business year 2007, consolidated revenues increased by 28.6 percent to EUR 180.2 million. In the HPS segment, revenues increased by 22.9 percent to EUR 104.6 million. HCS segment revenues increased by 27.1 percent to EUR 72.8 million. The EPS segment reached revenues in the amount of EUR 5.2 million, thus also showing a slight increase.

Adjusted Group EBITDA improved by 34.7 Percent
The adjusted consolidated earnings before interest, taxes, depreciation and amortization (EBITDA) increased by 34.7 percent to EUR 51.6 million in the past business year. In the HPS segment, EBITDA increased by 49.8 percent compared to the last year to an amount of EUR 22.7 million. The HCS segment continues to show strong profitability with an EBITDA of EUR 37.5 million in the business year 2007. Another improvement could be achieved in the EPS segment. Here the EBITDA is EUR -2.6 million.

Net Income has doubled: EUR 22.84 Million – Cash Earnings per Share have risen to EUR 0.78
The costs of the IPO as well as a revaluation of deferred taxes due to lowered corporate taxes had the expected positive, yet exceptional influence of EUR 7.7 million on the reported tax rate. As a result, the annual net income increased above average by 100.5 percent to EUR 22.8 million. The adjusted earnings per share (Cash EPS based on Cash Net Income) amount to EUR 0.78 compared to EUR 0.55 in the previous business year. This reflects a PE of about 15 for the year 2007. In the light of CompuGROUP's strong penchant for growth, it is clear that the company's shares promise to perform particularly well in the future.

Highlights in 2007
In 2007 CompuGROUP has further strengthened its international presence and consistently invested in the strategic expansion of all three business segments HPS, HCS and EPS.

Thus the company's basis for further growth in the international market has once more expanded significantly: Its access to doctors in governmental healthcare in Europe has increased remarkably. No other eHealth provider on the continent has such a large customer basis of doctors in governmental healthcare as CompuGROUP.

The newest pillar of CompuGROUP's business model – the company's portfolio of innovative software products for hospitals and clinics – has turned into a success story right after its introduction. The integration of hospitals into CompuGROUP's network offers them completely new perspectives when it comes to increasing their efficiency in times of ever-rising costs.

Faced with ongoing, massive structural changes of the German healthcare system which focus primarily on new concepts for the allocation of medical care, CompuGROUP responded with a ground-breaking innovation in 2007: For the first time, the history of complex medical treatments can be tracked and electronically mapped for individual patients to be supplemented with software-based suggestions for treatment in the managed care context. CompuGROUP has developed a complete software solution for the mapping of comprehensive managed care contracts covering a large variety of medical indications. A high demand for such solutions in the future from both governmental as well as private health insurances are expected.

Number of Employees Has Grown
As of December 31, 2007, the holding employed a total of 1,692 persons. This represents a 28-percent increase or 371 persons compared to the previous year.

Outlook for 2008: Further Growth of Revenues and EBITDA
Based on the product portfolio's further strategic development across all segments, as well as on the continuously fostered market cultivation and increasing demand for CompuGROUP's products, an even stronger business growth surpassing the results of 2007 is expected. For the business year 2008, the management board of CompuGROUP expects consolidated revenues of at least EUR 215 million and an EBITDA of at least EUR 65 million.

Related news articles:

About CompuGROUP Holding AG
CompuGROUP is one of the leading eHealth companies in Europe. Its software products, designed to support all medical and organizational activities in doctors’ surgeries and hospitals, its information services for all involved parties within the healthcare system and its web-based personal health records contribute to safer and more efficient healthcare. The services of CompuGROUP are centered on its unique customer base of around 300,000 doctors, dentists, hospitals, associations and networks as well as other service providers. CompuGROUP operates in 9 European countries and currently employs around 1,800 people. For more information, visit www.compugroup.com.

Most Popular Now

Study Finds One-Year Change on CT Scans …

Researchers at National Jewish Health have shown that subtle increases in lung scarring, detected by an artificial intelligence-based tool on CT scans taken one year apart, are associated with disease...

Yousif's Story with Sectra and The …

Embarking on healthcare technology career after leaving his home as a refugee during his teenage years, Yousif is passionate about making a difference. He reflects on an apprenticeship in which...

New AI Tools Help Scientists Track How D…

Artificial intelligence (AI) can solve problems at remarkable speed, but it’s the people developing the algorithms who are truly driving discovery. At The University of Texas at Arlington, data scientists...

AI Tool Offers Deep Insight into the Imm…

Researchers explore the human immune system by looking at the active components, namely the various genes and cells involved. But there is a broad range of these, and observations necessarily...

New Antibiotic Targets IBD - and AI Pred…

Researchers at McMaster University and the Massachusetts Institute of Technology (MIT) have made two scientific breakthroughs at once: they not only discovered a brand-new antibiotic that targets inflammatory bowel diseases...

Highland to Help Companies Seize 'N…

Health tech growth partner Highland has today revealed its new identity - reflecting a sharper focus as it helps health tech companies to find market opportunities, convince target audiences, and...